Broadfoot Jill Marie 4
4 · ACELRX PHARMACEUTICALS INC · Filed Dec 13, 2023
Insider Transaction Report
Form 4
Broadfoot Jill Marie
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-10+3,487→ 3,487 totalExercise: $0.68From: 2024-10-10Exp: 2033-10-10→ Common Stock (3,487 underlying) - Award
Common Stock
2023-10-10+581→ 2,106 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
- [F3]Effective on October 25, 2022, the issuer effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F4]100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.